Giaconda Limited (GIA, formerly Giaconda Pty Limited) is a
biotechnology company involved in developing and licensing
innovative and cost effective medical therapies in the field
of gastroenterology. The Giaconda portfolio consists of five
products, all of which are novel combinations of known
compounds. Giaconda has two lead products, Myocondo and Heliconda.